Cipla News

Cipla Limited (India) News

Pediatric Tamiflu Story

Pediatric Tamiflu Story

ABC News - 1 hour ago
ABC News -- An update to a story that aired on the broadcast Thursday, November 4. Our report on shortages of the pediatric liquid form of Tamiflu said: An Indian company, Cipla says it could ...

Emergency pills to maintain OTC drug status

Emergency pills to maintain OTC drug status

Financial Express - 52 minutes ago
New Delhi: In what comes as a relief to the largest domestic drug firm Cipla and Delhi-based Mankind Pharma which were accused for going overboard with promotion of 'morning after pills', the ...

Panel to decide on OTC sale of morning after pills

Panel to decide on OTC sale of morning after pills

mydigitalfc.com - 10 minutes ago
By Rakesh Khar Nov 08 2009 -I-pill' and 'Unwanted 72, promoted by Cipla and Man-kind Pharma, would continue to be sold over the counter (OTC). These pills are among the most advertised among the ...

Heard on the street

Heard on the street

Economic Times - 6 minutes ago
Analysts tracking the pharma sector were in for a pleasant surprise recently, after Cipla held a conference call for them after the second quarter earnings. This is because Cipla has earned the ...

Meda AB (publ) - Interim report, January -September 2009

Meda AB (publ) - Interim report, January -September 2009

Reuters - 2 minutes ago
STOCKHOLM, Sweden--(Business Wire)-- Regulatory News: • The Group`s net sales reached SEK 9,918 million (7,515), a 32% increase compared to the previous year. • EBITDA rose 28% to SEK 3,356 ...

SC issues notices to Centre, others on Novartis petition

SC issues notices to Centre, others on Novartis petition

Trading Markets - 8 minutes ago
New Delhi, Sep 11, 2009 (Asia Pulse Data Source via COMTEX) -- NAPHF -- The Supreme Court of India Friday issued notices to Indian government, pharma major Cipla, Ranbaxy Lab, Hetero Drugs, Natco ...

Forex gains push Cipla Q2 net up 82%

Forex gains push Cipla Q2 net up 82%

Business Standard - 8 minutes ago
An increase in exports — mainly of active pharmaceutical ingredients (API) — and foreign exchange gains have helped Cipla, the domestic drug major, post a jump of 82.1 per cent in its net profit ...

Different product mix helped cut material costs

Different product mix helped cut material costs

Livemint - 1 hour ago
Mumbai: Drug maker Cipla Ltd said net profit in the three months ended 30 September rose 82.78% to Rs276 crore, compared with Rs151 crore in the year-ago period. Chairman and managing director YK ...

Syndicate content